Browsing Over 268 Presentations
Sort By
Biomarkers (host related)
Educational session
Mining the microbiomes for biomarkers in cancer immune therapy (ID 15)
Lecture Time
16:30 - 16:50
Speakers
- J. Wargo (Houston, United States of America)
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
13.12.2018
Time
16:30 - 18:00
Authors
- J. Wargo (Houston, United States of America)
What’s new in chest tumours
Educational session
Immunotherapy in locally advanced NSCLC (ID 37)
Lecture Time
14:55 - 15:15
Speakers
- E. Felip (Barcelona, Spain)
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
14.12.2018
Time
14:15 - 15:45
Authors
- E. Felip (Barcelona, Spain)
What’s new in genitourinary (GU) tumours
Educational session
Session DOI (ID 511)
Lecture Time
09:10 - 09:10
Session Name
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
15.12.2018
Time
09:10 - 10:40
Immuno-oncology endpoints for approval: The case of tumor agnostic approval for MSI-H cancers
Panel Discussion
Discussion led by Chairs (ID 187)
Lecture Time
08:20 - 09:00
Session Name
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
16.12.2018
Time
08:00 - 09:00
Introduction to immunotherapy in cancer
Educational session
Immune checkpoints: Do we really know how they work? (ID 234)
Lecture Time
11:55 - 12:15
Speakers
- J. B. Haanen (Amsterdam, Netherlands)
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
13.12.2018
Time
11:15 - 12:45
Authors
- J. B. Haanen (Amsterdam, Netherlands)
Biomarkers (tumour related)
Educational session
Understanding the mechanisms to develop combinations of immunoregulatory agents with radiotherapy (ID 30)
Lecture Time
11:00 - 11:20
Speakers
- E. Cheadle (Manchester, United Kingdom)
Session Name
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
14.12.2018
Time
11:00 - 12:30
Authors
- E. Cheadle (Manchester, United Kingdom)
Immuno-oncology: State of the art I
Educational session
Arginase inhibition to modulate the TME: Rationale and early clinical experience (ID 104)
Lecture Time
09:10 - 09:30
Speakers
- S. Ioannidis (Epalinges, Not Applicable, Switzerland)
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
15.12.2018
Time
09:10 - 10:40
Authors
- S. Ioannidis (Epalinges, Not Applicable, Switzerland)
What’s new in breast & gynaecological cancers
Educational session
General discussion / Q&A (ID 79)
Lecture Time
17:35 - 17:45
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
15.12.2018
Time
16:15 - 17:45
What’s new in brain tumours
Educational session
Session DOI (ID 501)
Lecture Time
11:00 - 11:00
Session Name
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
16.12.2018
Time
11:00 - 12:30
Management of side effects
Educational session
Requirements for safely administering combination of ipilimumab + nivolumab (ID 27)
Lecture Time
09:40 - 10:00
Speakers
- H. Kluger (New Haven, United States of America)
Session Name
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
14.12.2018
Time
09:00 - 10:30
Authors
- H. Kluger (New Haven, United States of America)
Intratumoural immunotherapy
Educational session
General discussion / Q&A (ID 49)
Lecture Time
17:35 - 17:45
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
14.12.2018
Time
16:15 - 17:45
What’s new in haematological malignancies
Educational session
BiTE antibodies in hematological malignancies (ID 71)
Lecture Time
14:15 - 14:35
Speakers
- R. Bargou (Würzburg, Germany)
Session Name
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
15.12.2018
Time
14:15 - 15:45
Authors
- R. Bargou (Würzburg, Germany)